Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Income towards Parent Company (2021 - 2023)

Updated

Nika Pharmaceuticals (NIKA) recorded Income towards Parent Company of -$10,143 in Q3 2023, compared with -$6,339 a year earlier.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Income towards Parent Company (2021 - 2023) Analysis & Trends

On a TTM basis, Nika Pharmaceuticals' Income towards Parent Company came in at -$72,569 as of Sep 30, 2023; for FY2022, it was -$3.18 million.

  • Across earlier years, Income towards Parent Company came in at -$14,712 in FY2021.
  • Quarterly Income towards Parent Company has ranged from -$3.16 million in Q2 2022 to $5,754 in Q1 2021 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$27,806 (Q2 2023), -$19,570 (Q1 2023) and -$15,050 (Q4 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -10,143.00
Jun 30, 2023 -27,806.00
Mar 31, 2023 -19,570.00
Dec 31, 2022 -15,050.00
Sep 30, 2022 -6,339.00
Jun 30, 2022 -3.16 Mn
Mar 31, 2022 -6,316.00
Dec 31, 2021 -26,124.00
Sep 30, 2021 2,699.00
Jun 30, 2021 2,959.00
Mar 31, 2021 5,754.00
API Access

Nika Pharmaceuticals, Inc Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=NIKA&period=max&api_key=YOUR_API_KEY